Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

796
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
796
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

459
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
459
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

516
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
516
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

872
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
872
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

1.3K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.3K
Other Pulmonary Disorders01:17

Other Pulmonary Disorders

1.4K
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
1.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

PD-L1-centric whole blood-based immune signature profiles of tuberculosis patients during therapy.

Frontiers in immunology·2026
Same author

Individualized Therapy Guided by Drug Susceptibility Testing for Multidrug-Resistant Tuberculosis.

Open forum infectious diseases·2026
Same author

Antibiotic pressure does not uncover intra-host heterogeneity of Pseudomonas aeruginosa in patients with chronic lung disease.

BMC microbiology·2026
Same author

Robust antibiotic sensitization of pathogenic Pseudomonas aeruginosa via negative hysteresis in the cell envelope.

Nature communications·2026
Same author

Towards model-informed precision dosing of clofazimine, moxifloxacin, and terizidone/cycloserine in the treatment of drug-resistant tuberculosis: An external model evaluation study.

Tuberculosis (Edinburgh, Scotland)·2026
Same author

Correction to Diagnostic accuracy and predictive value of the QuantiFERON-TB gold plus assay for tuberculosis in immunocompromised individuals: a prospective TBnet study Lancet Reg Health Eur 57 (2025) 101416 LLRHEUROPE-D-25-00310.

The Lancet regional health. Europe·2025
Same journal

Der Internist·2024
Same journal

Der Internist·2024
Same journal

Der Internist·2024
Same journal

Der Internist·2024
Same journal

Der Internist·2024
Same journal

Der Internist·2024
See all related articles

Related Experiment Video

Updated: Jan 5, 2026

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

19.2K

[Tuberculosis].

Christoph Lange1,2,3,4, Barbara Kalsdorf5,6, Florian P Maurer7

  • 1Medizinische Klinik, Forschungszentrum Borstel, Leibniz Lungenzentrum, Parkallee 35, 23845, Borstel, Deutschland. clange@fz-borstel.de.

Der Internist
|October 24, 2019
PubMed
Summary
This summary is machine-generated.

Tuberculosis (TB) is a bacterial infection diagnosed using imaging and various tests. Effective treatment regimens achieve high cure rates for both drug-susceptible and drug-resistant TB.

Keywords:
Interferon-γ release testsMycobacterium tuberculosisTuberculosis therapyTuberculosis, multidrug-resistantTuberculosis, pulmonary

More Related Videos

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
23:06

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

Published on: August 11, 2008

19.5K
A Tuberculosis Molecular Bacterial Load Assay TB-MBLA
10:41

A Tuberculosis Molecular Bacterial Load Assay TB-MBLA

Published on: April 30, 2020

14.6K

Related Experiment Videos

Last Updated: Jan 5, 2026

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

19.2K
The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
23:06

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

Published on: August 11, 2008

19.5K
A Tuberculosis Molecular Bacterial Load Assay TB-MBLA
10:41

A Tuberculosis Molecular Bacterial Load Assay TB-MBLA

Published on: April 30, 2020

14.6K

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Public Health

Background:

  • Tuberculosis (TB) is a significant global bacterial infectious disease, with an estimated 10 million new cases in 2017.
  • Transmission typically occurs through inhalation of infectious droplets.
  • Accurate and timely diagnosis is crucial for effective patient management and disease control.

Purpose of the Study:

  • To outline the diagnostic approaches for tuberculosis.
  • To describe current treatment strategies for both drug-susceptible and multidrug-resistant tuberculosis.
  • To highlight the importance of genotypic and phenotypic methods in TB diagnosis and management.

Main Methods:

  • Diagnostic methods include imaging, microbiological, molecular, and immunological tests.
  • Genotypic methods offer early diagnosis and drug resistance prediction.
  • Phenotypic (culture-based) methods serve as the diagnostic gold standard.

Main Results:

  • Standard treatment for pan drug-susceptible pulmonary TB involves a 6-month regimen with high cure rates (>80%).
  • Individualized treatment schemes can achieve comparable cure rates for multidrug-resistant TB.
  • Rapid diagnostic tools, including genotypic methods, are essential for early detection and guiding therapy.

Conclusions:

  • Effective management of tuberculosis relies on a combination of advanced diagnostic techniques and tailored treatment regimens.
  • High cure rates are achievable for both drug-susceptible and multidrug-resistant tuberculosis with appropriate medical intervention.
  • Continued research and application of molecular diagnostics are vital for combating the global TB burden.